Simulating the response of the library of DLBCL lines to BH3-mimetics targeting BCL2, BCL-xL and MCL1 predicted highly heterogeneous responses (Fig. 3B). The gene discussed is MCL1; the disease is diffuse large B-cell lymphoma.